Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RESOURCES CONNECTION, INC.RGP · Entity 6553 | Director | September 26, 2025 | September 29, 2025 |
| Viatris IncVTRS · Entity 3277 | Director | March 21, 2022 | March 23, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RESOURCES CONNECTION, INC.
Report date September 26, 2025 · Filed September 29, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 68,682 |
Reported balance
After 2025-09-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-09-26 · Grant · Acquired 929 · Balance 68,682 F1: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan.
Viatris Inc
Report date March 21, 2022 · Filed March 23, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 75,200 |
Reported balance
After 2022-03-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-21 · Exercise / conversion · Acquired 166 · Balance 75,200 F1: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. F2: The total reported in Column 5 has been adjusted by 30 shares to correct an understatement of total holdings first reflected in the reporting person's Form 4 filed on March 4, 2022. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 165.5224 |
Reported balance
After 2022-03-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-21 · Grant · Acquired 165.5224 · Balance 165.5224 F3: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2022-03-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-03-21 · Exercise / conversion · Disposed 165.5224 · Balance 0 F3: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
F2: The total reported in Column 5 has been adjusted by 30 shares to correct an understatement of total holdings first reflected in the reporting person's Form 4 filed on March 4, 2022.
F3: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Alliance HealthCare Services, Inc
Report date August 21, 2017 · Filed August 22, 2017
Section 16 reporting ended · disclosed 2017-08-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-21 transaction · row 1
1 source rowRow 1 · 2017-08-21 · Disposition to issuer · Disposed 70,817 · Balance 0 F1: Disposed of pursuant to the closing of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of April 10, 2017 by and among the Issuer, Tahoe Investment Group Co., Ltd., THAIHOT Investment Company Limited, THAIHOT Investment Company US Limited and Alliance Healthcare Services Merger Sub Limited. Each share of Issuer common stock held by the reporting person was cancelled in the merger and converted into the right to receive $13.25 in cash per share, without interest and less any applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the closing of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of April 10, 2017 by and among the Issuer, Tahoe Investment Group Co., Ltd., THAIHOT Investment Company Limited, THAIHOT Investment Company US Limited and Alliance Healthcare Services Merger Sub Limited. Each share of Issuer common stock held by the reporting person was cancelled in the merger and converted into the right to receive $13.25 in cash per share, without interest and less any applicable withholding taxes.
Mylan II B.V.
Report date November 16, 2020 · Filed November 18, 2020
Section 16 reporting ended · disclosed 2020-11-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-11-16 · Disposition to issuer · Disposed 51,263 · Balance 0 F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $45.72 · Expires 2024-04-11 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-11-16 · Disposition to issuer · Disposed 2,974 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4: These options vested on April 11, 2015. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $50.66 · Expires 2025-11-17 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-11-16 · Disposition to issuer · Disposed 2,603 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F5: These options vested on May 1, 2016. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $46.27 · Expires 2026-02-17 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-11-16 · Disposition to issuer · Disposed 2,788 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F6: These options vested on February 17, 2017. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $45.18 · Expires 2027-03-03 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-11-16 · Disposition to issuer · Disposed 2,928 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F7: These options vested on March 3, 2018. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $40.97 · Expires 2028-03-02 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-11-16 · Disposition to issuer · Disposed 2,984 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F8: These options vested on March 2, 2019. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $27.45 · Expires 2029-03-01 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2020-11-16 · Disposition to issuer · Disposed 4,352 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F9: These options vested on March 2, 2020. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $17.48 · Expires 2030-03-02 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-11-16 · Disposition to issuer · Disposed 6,151 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F10: These options will vest on March 2, 2021. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-11-16 · Disposition to issuer · Disposed 9,440 · Balance 0 F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F12: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax).
F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.
F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.
F4: These options vested on April 11, 2015.
F5: These options vested on May 1, 2016.
F6: These options vested on February 17, 2017.
F7: These options vested on March 3, 2018.
F8: These options vested on March 2, 2019.
F9: These options vested on March 2, 2020.
F10: These options will vest on March 2, 2021.
F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination.
F12: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021.
WebMD Health Corp.
Report date September 15, 2017 · Filed September 15, 2017
Section 16 reporting ended · disclosed 2017-09-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 1
1 source rowRow 1 · 2017-09-15 · Other · Disposed 13,862 · Balance 0 F1: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement"). |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.07 · Expires 2018-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.54 · Expires 2019-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-09-15 · Disposition to issuer · Disposed 8,888 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.49 · Expires 2020-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.55 · Expires 2022-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.34 · Expires 2023-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.50 · Expires 2024-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.55 · Expires 2025-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.30 · Expires 2026-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.57 · Expires 2027-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
Filing footnotes · ownership attribution and instrument terms
F1: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement").
F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 26, 2025 Filed Sep 29, 2025 20:19 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 929 | $0.00 | $0.00 |
DisclosureSEC source: 0001248380-25-000005 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,682 Underlying: Common Stock · 929 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| July 21, 2025 Filed Jul 23, 2025 20:35 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 895 | $0.00 | $0.00 |
DisclosureSEC source: 0001084765-25-000100 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,753 Underlying: Common Stock · 895 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| March 14, 2025 Filed Apr 3, 2025 21:08 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 1,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001084765-25-000045 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,858 Underlying: Common Stock · 1,327 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:31 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 11,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001084765-25-000021 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,531 Underlying: Common Stock · 11,467 shares Expires not disclosed F1 · derivative.exercise_price: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 23:04 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 901 | $0.00 | $0.00 |
DisclosureSEC source: 0001084765-24-000178 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,064 Underlying: Common Stock · 901 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 21:03 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 736 | $0.00 | $0.00 |
DisclosureSEC source: 0001084765-24-000132 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,163 Underlying: Common Stock · 736 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:13 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 673 | $0.00 | $0.00 |
DisclosureSEC source: 0001084765-24-000080 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,427 Underlying: Common Stock · 673 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 20:38 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0001084765-24-000031 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,754 Underlying: Common Stock · 550 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 22:09 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 7,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001084765-24-000015 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,204 Underlying: Common Stock · 7,153 shares Expires not disclosed F1 · derivative.exercise_price: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 22:11 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 419 | $0.00 | $0.00 |
DisclosureSEC source: 0001084765-23-000059 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,051 Underlying: Common Stock · 419 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| September 21, 2023 Filed Sep 22, 2023 21:52 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 394 | $0.00 | $0.00 |
DisclosureSEC source: 0001084765-23-000032 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,632 Underlying: Common Stock · 394 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 21:56 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001248380-23-000006 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,238 Underlying: Common Stock · 373 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 21:34 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 332 | $0.00 | $0.00 |
DisclosureSEC source: 0001248380-23-000004 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,865 Underlying: Common Stock · 332 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Represents dividend equivalent phantom shares accrued on previously awarded phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. These shares of phantom stock will become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 23:34 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 5,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001248380-23-000002 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,533 Underlying: Common Stock · 5,393 shares Expires not disclosed F1 · derivative.exercise_price: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.exercise_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F2 · balance_after: Includes 3,856 phantom shares credited as dividend equivalent phantom shares in accordance with the terms of the Directors Deferred Compensation Plan. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 165.5224 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011982 · doc4.xml · derivative · entry 3 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 165.5224 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. F3 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:00 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 165.5224 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011982 · doc4.xml · derivative · entry 2 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165.5224 Underlying: Common Stock · 165.5224 shares Expires not disclosed F3 · derivative.exercise_price: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. F3 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. F3 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011982 · doc4.xml · nonDerivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. F2 · balance_after: The total reported in Column 5 has been adjusted by 30 shares to correct an understatement of total holdings first reflected in the reporting person's Form 4 filed on March 4, 2022. Read SEC document |
| March 04, 2022 Filed Mar 4, 2022 19:58 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 19,608 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009530 · doc4.xml · derivative · entry 5 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,608 Underlying: Common Stock · 19,608 shares Expires not disclosed F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2023. F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2023. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 19:58 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 334.4826 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009530 · doc4.xml · derivative · entry 4 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 334.4826 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents dividend equivalent units that accrued with respect to the RSUs previously granted on March 2, 2021 and vested on the same schedule as the underlying RSUs. F3 · derivative.expiration_date: Represents dividend equivalent units that accrued with respect to the RSUs previously granted on March 2, 2021 and vested on the same schedule as the underlying RSUs. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 19:58 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 13,996 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009530 · doc4.xml · derivative · entry 3 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,996 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 2, 2022. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 19:58 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009530 · doc4.xml · nonDerivative · entry 2 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 19:58 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 13,996 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009530 · doc4.xml · nonDerivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:05 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 5,534 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001248380-22-000002 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,284 Underlying: Common Stock · 5,534 shares Expires not disclosed F1 · derivative.exercise_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. F1 · derivative.expiration_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock to the extent then-vested become payable in cash to the reporting person upon separation from service as a director in accordance with the reporting person's election under the Directors Deferred Compensation Plan. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 18:01 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 120.0574 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-049647 · doc4.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334.4826 Underlying: Common Stock · 120.0574 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 18:01 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 113.2715 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-037660 · doc4.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214.4252 Underlying: Common Stock · 113.2715 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:30 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 101.1537 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-025577 · doc4.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101.1537 Underlying: Common Stock · 101.1537 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 9,440 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009924 · doc4.xml · derivative · entry 3 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,440 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 2, 2021. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 13,996 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009924 · doc4.xml · derivative · entry 2 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,996 Underlying: Common Stock · 13,996 shares Expires not disclosed F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. ("Viatris"). These RSUs will vest on March 2, 2022. F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. ("Viatris"). These RSUs will vest on March 2, 2022. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 9,440 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009924 · doc4.xml · nonDerivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 02:32 UTC | RESOURCES CONNECTION, INC. RGP · Entity 6553 | GrantPhantom Stock · Derivative | 8,058 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001248380-21-000002 · edgardoc.xml · derivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,750 Underlying: Common Stock · 8,058 shares Expires not disclosed F1 · derivative.exercise_date: Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash to the reporting person upon separation from service as a director. F1 · derivative.expiration_date: Represents credit of deferred compensation to reporting person's deferred stock account under the Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in cash to the reporting person upon separation from service as a director. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:53 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 9,440 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 9 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,440 Underlying: Common Stock · 9,440 shares Expires not disclosed F11 · security: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F11 · price: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F12 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F12 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:53 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 6,151 | Not disclosed Strike: $17.48 | Not disclosed |
DisclosureSEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 8 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,151 Underlying: Common Stock · 6,151 shares Expires 2030-03-02 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F10 · derivative.exercise_date: These options will vest on March 2, 2021 Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:53 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 4,352 | Not disclosed Strike: $27.45 | Not disclosed |
DisclosureSEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 7 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,352 Underlying: Common Stock · 4,352 shares Expires 2029-03-01 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F9 · derivative.exercise_date: These options vested on March 2, 2020. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:53 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 2,984 | Not disclosed Strike: $40.97 | Not disclosed |
DisclosureSEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 6 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,984 Underlying: Common Stock · 2,984 shares Expires 2028-03-02 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F8 · derivative.exercise_date: These options vested on March 2, 2019. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:53 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 2,928 | Not disclosed Strike: $45.18 | Not disclosed |
DisclosureSEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 5 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,928 Underlying: Common Stock · 2,928 shares Expires 2027-03-03 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F7 · derivative.exercise_date: These options vested on March 3, 2018. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:53 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 2,788 | Not disclosed Strike: $46.27 | Not disclosed |
DisclosureSEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 4 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,788 Underlying: Common Stock · 2,788 shares Expires 2026-02-17 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F6 · derivative.exercise_date: These options vested on February 17, 2017. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:53 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 2,603 | Not disclosed Strike: $50.66 | Not disclosed |
DisclosureSEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 3 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,603 Underlying: Common Stock · 2,603 shares Expires 2025-11-17 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F5 · derivative.exercise_date: These options vested on May 1, 2016. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:53 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 2,974 | Not disclosed Strike: $45.72 | Not disclosed |
DisclosureSEC source: 0000899243-20-031577 · doc4.xml · derivative · entry 2 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,974 Underlying: Common Stock · 2,974 shares Expires 2024-04-11 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F4 · derivative.exercise_date: These options vested on April 11, 2015. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:53 UTC | Viatris Inc VTRS · Entity 3277 | GrantCommon Stock | 51,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031577 · doc4.xml · nonDerivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,263 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents shares of Viatris common stock acquired in connection with the Combination on a one-for-one basis in exchange for ordinary shares of Mylan. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerRestricted Stock Units · Derivative | 9,440 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 9 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,440 shares Expires not disclosed F11 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F11 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F12 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. F12 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 6,151 | Not disclosed Strike: $17.48 | Not disclosed |
DisclosureSEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 8 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,151 shares Expires 2030-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F10 · derivative.exercise_date: These options will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 4,352 | Not disclosed Strike: $27.45 | Not disclosed |
DisclosureSEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 7 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,352 shares Expires 2029-03-01 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F9 · derivative.exercise_date: These options vested on March 2, 2020. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 2,984 | Not disclosed Strike: $40.97 | Not disclosed |
DisclosureSEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 6 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,984 shares Expires 2028-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F8 · derivative.exercise_date: These options vested on March 2, 2019. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 2,928 | Not disclosed Strike: $45.18 | Not disclosed |
DisclosureSEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 5 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,928 shares Expires 2027-03-03 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F7 · derivative.exercise_date: These options vested on March 3, 2018. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 2,788 | Not disclosed Strike: $46.27 | Not disclosed |
DisclosureSEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 4 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,788 shares Expires 2026-02-17 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F6 · derivative.exercise_date: These options vested on February 17, 2017. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 2,603 | Not disclosed Strike: $50.66 | Not disclosed |
DisclosureSEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 3 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,603 shares Expires 2025-11-17 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F5 · derivative.exercise_date: These options vested on May 1, 2016. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 2,974 | Not disclosed Strike: $45.72 | Not disclosed |
DisclosureSEC source: 0000899243-20-031512 · doc4.xml · derivative · entry 2 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,974 shares Expires 2024-04-11 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4 · derivative.exercise_date: These options vested on April 11, 2015. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:20 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerOrdinary Shares | 51,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031512 · doc4.xml · nonDerivative · entry 1 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 18:32 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionRestricted Stock Units · Derivative | 6,011 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007020 · doc4.xml · derivative · entry 5 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,011 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on March 2, 2020. F4 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on March 2, 2020. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 18:32 UTC | Mylan II B.V. MYL · Entity 16217 | GrantRestricted Stock Units · Derivative | 9,440 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007020 · doc4.xml · derivative · entry 4 DIMICK NEIL F · CIK 0001248380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,440 Underlying: Ordinary Shares · 9,440 shares Expires not disclosed F3 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 2, 2021. F3 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 2, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.